The Biological Stains market size is expected to reach $12.63 billion in 2030 at a CAGR of 6.6%, driven by growth of pharmaceutical and biotechnology industries.
Read More
The Biologic & Biosimilar RA Drugs market size is expected to reach $20.53 billion in 2030 at a CAGR of 7.2%, driven by rising global healthcare spending.
Read More
The Bioengineered Protein Drugs market size is expected to reach $646.93 billion in 2030 at a CAGR of 8.4%, driven by increasing prevalence of chronic diseases.
Read More
The Biodegradable Medical Polymers market size is expected to reach $5.95 billion in 2030 at a CAGR of 16.4%, driven by rising demand for minimally invasive procedures.
Read More
The Bioconvergence market size is expected to reach $263.67 billion in 2030 at a CAGR of 10.8%, driven by growing emphasis on personalized medicine solutions.
Read More
The Biobetters market size is expected to reach $121.61 billion in 2030 at a CAGR of 9.7%, driven by increasing prevalence of chronic and autoimmune diseases.
Read More
The Biobased Disinfectant market size is expected to reach $9.46 billion in 2030 at a CAGR of 9.6%, driven by growing awareness of environmental sustainability.
Read More
The Biguanides market size is expected to reach $5.97 billion in 2030 at a CAGR of 3.1%, driven by rising prevalence of diabetes and metabolic disorders.
Read More
The Bevacizumab Biosimilars market size is expected to reach $2.42 billion in 2030 at a CAGR of 8.2%, driven by rising global prevalence of cancer cases.
Read More
The Beta Blockers market size is expected to reach $13.96 billion in 2030 at a CAGR of 6.6%, driven by increasing incidence of cardiovascular diseases globally.
Read More